Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

JBI 1527

X
Drug Profile

JBI 1527

Alternative Names: JBI-1527; JTi - Jubilant Therapeutics

Latest Information Update: 16 Jun 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Jubilant Therapeutics
  • Class Antineoplastics; Small molecules
  • Mechanism of Action Programmed cell death-1 ligand-1 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 14 Jun 2021 Jubilant Therapeutics plans to file an IND application with the US FDA for Cancer in the first half of 2022 (Jubilant Therapeutics pipeline, June 2021)
  • 14 Jun 2021 Jubilant Therapeutics plans a clinical trial for Cancer in USA (Jubilant Therapeutics pipeline, June 2021)
  • 11 Jun 2021 JBI 1527 is available for licensing as of 11 Jun 2021. https://www.jubilanttx.com/collaborations

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top